Circulating tumor cells and biomarker modulation with olaratumab monotherapy followed by olaratumab plus doxorubicin: Phase ib study in patients with soft-tissue sarcoma
Javier Martín-Broto, A. L. Pousa, Andrew S. Brohl, Brian A. van Tine, Benjamin Powers, Silvia Stacchiotti, Jean Yves Blay, James S. Hu, Gerard J. Oakley, Hong Wang, Anna M. Szpurka, Donna E. Levy, Gary Mo, Matteo Ceccarelli, Robin L. Jones
Dive into the research topics of 'Circulating tumor cells and biomarker modulation with olaratumab monotherapy followed by olaratumab plus doxorubicin: Phase ib study in patients with soft-tissue sarcoma'. Together they form a unique fingerprint.